困難な条件下での結核治療―透析患者における結核治療

• 横山 俊伸

  久留米大学第一内科

• 力丸 徹合

  久留米大学第一内科

• 合原 るみ

  久留米大学第一内科

• 渡邊 尚

  久留米大学第一内科

• 相澤 久道

  久留米大学第一内科

書誌事項

タイトル別名

• TUBERCULOSIS IN PATIENTS UNDERGOING HEMODIALYSIS
• コンナン ナ ジョウケン カ デ ノ ケッカク チリョウ : トウセキ カンジャ ニ オケル ケッカク チリョウ
• 透析患者における結核治療

抄録

We studied patients who were diagnosed as active tuberculosis while undergoing hemodialysis at Kurume University Hospital. The observation included immunologic and clinical features. Cellular immunity was depressed in our patients undergoing hemodialysis, as evident from the decreased numbers of lymphocytes and anergy to tuberculin skin tests with purified protein derivative (PPD). Further, in a few patients, hemodialysis was shown to eliminate IFN-γ from the blood. Various antituberculous chemotherapy regimens have been studied in hemodialysis patients. Although the incidence and mortality of tuberculosis have been reported to be higher in hemodialysis patients than in the general population, the clinical outcome of our cases was favorable in this study. One important notice is to recognizepromptly peripheral neuropathy while treating tuberculosis associated with hemodialysis, and this could be prevented by the adequate use of pyridoxine.

収録刊行物

• 結核

  結核 78 (7), 483-486, 2003

  一般社団法人 日本結核病学会

キーワード

• 結核
• 血液透析
• ツベルクリン反応

詳細情報

• CRID: 1390282679978023424
• NII論文ID: 10011426284
• NII書誌ID: AN00073442
• DOI: 10.11400/kekkaku1923.78.483
• ISSN: 18842410
• ISSN: 00229776
• NDL書誌ID: 026803927
• PubMed: 12931645
• Web Site: https://ndlsearch.ndl.go.jp/books/R000000004-I026803927
• Web Site: https://search.jamas.or.jp/link/ui/2003311293
• 本文言語コード: ja
• データソース種別:
  • JaLC
  • NDL
  • PubMed
  • CiNii Articles
• 抄録ライセンスフラグ: 使用不可